文献速递心血管MR

缺血介导的亚乳头肌心肌功能障碍作为功能性二尖瓣反流标志物

Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-03-17

本研究在7个中心对8631例已知或疑似冠心病患者行血管扩张剂负荷心脏磁共振,中心分析二尖瓣反流病因/严重程度、二尖瓣装置重构及乳头肌缺血。结果显示,缺血/功能障碍的亚乳头肌心肌与晚期功能性二尖瓣反流相关(OR 1.24/10%亚乳头肌心肌),且晚期功能性二尖瓣反流独立预测死亡(HR 1.52)。

要点

  • 亚乳头肌区域缺血与晚期功能性二尖瓣反流相关,其他区域缺血无此关联。
  • 缺血/功能障碍的亚乳头肌心肌每增加10%,晚期功能性二尖瓣反流风险OR为1.24。
  • 晚期功能性二尖瓣反流患者死亡风险增加,HR 1.52(95%CI 1.25-1.86)。

关键影像表现/征象

  • 缺血局限于亚乳头肌区域的患者更易出现晚期功能性二尖瓣反流(p=0.003),缺血局限于其他区域则无此关联(p=0.17)。
  • 晚期功能性二尖瓣反流患者二尖瓣装置重构增加,同时伴有更多缺血/功能障碍的亚乳头肌心肌(p<0.001)。
  • 晚期功能性二尖瓣反流患者中后内侧乳头肌缺血更常见(p=0.006),但校正后内侧乳头肌缺血后亚乳头肌缺血伴功能障碍仍与晚期功能性二尖瓣反流相关(p<0.001)。

诊断标准与关键数值

  • 缺血/功能障碍的亚乳头肌心肌与晚期功能性二尖瓣反流相关,OR 1.24/10%亚乳头肌心肌(95%CI 1.17-1.31,p<0.001),校正梗死。
  • 晚期功能性二尖瓣反流增加死亡风险,HR 1.52(95%CI 1.25-1.86,p<0.001),校正左心室射血分数、梗死和缺血。

临床应用与阅片要点

  • 在负荷心脏磁共振中评估亚乳头肌心肌缺血/功能障碍可能有助于识别功能性二尖瓣反流风险患者。
  • 报告功能性二尖瓣反流时应注意描述二尖瓣装置重构及乳头肌缺血情况。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The goal of this study was to test whether ischemia-mediated contractile dysfunction underlying the mitral valve affects functional mitral regurgitation (FMR) and the prognostic impact of FMR.

BACKGROUND: FMR results from left ventricular (LV) remodeling, which can stem from myocardial tissue alterations. Stress cardiac magnetic resonance can assess ischemia and infarction in the left ventricle and papillary muscles; relative impact on FMR is uncertain.

METHODS: Vasodilator stress cardiac magnetic resonance was performed in patients with known or suspected coronary artery disease at 7 sites. Images were centrally analyzed for MR etiology/severity, mitral apparatus remodeling, and papillary ischemia.

RESULTS: A total of 8,631 patients (mean age 60.0 ± 14.1 years; 55% male) were studied. FMR was present in 27%, among whom 16% (n = 372) had advanced (moderate or severe) FMR. Patients with ischemia localized to subpapillary regions were more likely to have advanced FMR (p = 0.003); those with ischemia localized to other areas were not (p = 0.17). Ischemic/dysfunctional subpapillary myocardium (odds ratio: 1.24/10% subpapillary myocardium; confidence interval: 1.17 to 1.31; p < 0.001) was associated with advanced FMR controlling for infarction. Among a subgroup with (n = 372) and without (n = 744) advanced FMR matched (1:2) on infarct size/distribution, patients with advanced FMR had increased adverse mitral apparatus remodeling, paralleled by greater ischemic/dysfunctional subpapillary myocardium (p < 0.001). Although posteromedial papillary ischemia was more common with advanced FMR (p = 0.006), subpapillary ischemia with dysfunction remained associated (p < 0.001), adjusting for posteromedial papillary ischemia (p = 0.074). During follow-up (median 5.1 years), 1,473 deaths occurred in the overall cohort; advanced FMR conferred increased mortality risk (hazard ratio: 1.52; 95% confidence interval: 1.25 to 1.86; p < 0.001) controlling for left ventricular ejection fraction, infarction, and ischemia.

CONCLUSIONS: Ischemic and dysfunctional subpapillary myocardium provides a substrate for FMR, which predicts mortality independent of key mechanistic substrates.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Kochav JD, Kim J, Judd R, et al. Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation. JACC Cardiovasc Imaging. 2021. PMID: 33744130. doi:10.1016/j.jcmg.2021.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。